• To understand what AATD is and what the consequences are for an individual with COPD

  • To identify the target clientele who should be tested for AATD

  • To understand the diagnostic process

  • To understand the treatment, including augmentation therapy, as well as long-term adherence and lifestyle improvements to live better with AATD

About Our Speaker

Miriam Barrecheguren, MD, PhD

Dr. Miriam Barrecheguren is a pneumologist who currently works at Vall d’Hebron University Hospital in Barcelona. Her main areas of interest include COPD, AATD and mechanical ventilation. After earning her Ph.D. in 2016, on the diagnosis and management of COPD and AATD in Primary Care, she fulfilled a research fellow at McGill University and was then granted a Rio Hortega grant to continue her work in Barcelona. She is the Early Career representative for the European Respiratory Society (ERS) in the European Alpha-1 research collaboration (EARCO).